Rankings
▼
Calendar
BMY Q4 2016 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena
BMY
Bristol-Myers Squibb Company
$121B
Q4 2016 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$5.2B
Gross Profit
$3.7B
70.0% margin
Operating Income
$997M
19.0% margin
Net Income
$894M
17.1% margin
EPS (Diluted)
$0.53
QoQ Revenue Growth
+6.5%
Cash Flow
Operating Cash Flow
$1.4B
Free Cash Flow
$1.1B
Stock-Based Comp.
$56M
Balance Sheet
Total Assets
$33.7B
Total Liabilities
$17.4B
Stockholders' Equity
$16.2B
Cash & Equivalents
$4.2B
Revenue Segments
Opdivo
$1.3B
25%
Eliquis
$948M
18%
Orencia
$625M
12%
Mature Products And All Other
$550M
10%
Sprycel
$494M
9%
Baraclude
$296M
6%
Yervoy
$264M
5%
Sustiva Franchise
$246M
5%
Hepatitis C Portfolio
$226M
4%
Reyataz
$206M
4%
Empliciti
$47M
1%
Abilify
$31M
1%
← FY 2016
All Quarters
Q1 2017 →
